Tissue engineering strategies for in vivo neovascularisation
- 1 December 2002
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Biological Therapy
- Vol. 2 (8) , 805-818
- https://doi.org/10.1517/14712598.2.8.805
Abstract
Neovascularisation is a promising alternative therapeutic approach to re-establish blood flow in ischaemic tissues of patients suffering from coronary artery or peripheral artery disease. Often, these patients are not suitable candidates for current revascularisation procedures such as coronary angioplasty or bypass surgery. Several strategies are presently under investigation to induce vascularisation by stimulating the body's natural processes of vasculogenesis, angiogenesis and arteriogenesis. These strategies involve transplantation of various cell types into the ischaemic site and the delivery of recombinant angiogenic agents through direct protein administration or gene transfer. We will examine the basic approaches for these neovacularisation strategies and their therapeutic potential as demonstrated in animal models and human trials to date.Keywords
This publication has 82 references indexed in Scilit:
- Gene therapy for therapeutic angiogenesis in critically ischaemic lower limb – on the way to the clinicEuropean Journal of Clinical Investigation, 2001
- Endogenous angiogenesis inhibitors and their therapeutic implicationsThe International Journal of Biochemistry & Cell Biology, 2001
- Molecular mechanisms of blood vessel growthPublished by Oxford University Press (OUP) ,2001
- Vascular-specific growth factors and blood vessel formationNature, 2000
- Mechanisms of angiogenesis and arteriogenesisNature Medicine, 2000
- Blood vessel maturation: vascular development comes of ageJournal of Clinical Investigation, 1999
- Hemangioblast development and regulationBiochemistry and Cell Biology, 1998
- Fibroblast growth factors and their receptorsBiochemistry and Cell Biology, 1997
- VasculogenesisAnnual Review of Cell and Developmental Biology, 1995
- Transplacental Carcinogenesis by StilbestrolNew England Journal of Medicine, 1971